Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13192001 | 0.89 | TSHR (0.46) | TNKSTSHRMETAP2CA1CA2 | |
| SCHEMBL13192425 | 0.88 | MMP3 (0.47) | TNKSTSHRMETAP2CA1CA2 | |
| SCHEMBL13171012 | 0.86 | TSHR (0.48) | TNKSTSHRMETAP2CA1CA2 | |
| SCHEMBL3634282 | 0.82 | CA1 (0.44) | TNKSTSHRCA1CA2MAOB | |
| SCHEMBL13171073 | 0.81 | TNKS (0.43) | TNKSTSHRMETAP2CA1CA2 | |
| SCHEMBL29847362 | 0.81 | TSHR (0.41) | TNKSTSHRCA1CA2MAOB | |
| SCHEMBL21313428 | 0.81 | TSHR (0.41) | TNKSTSHRCA1CA2MAOB | |
| SCHEMBL14066870 | 0.81 | TNKS (0.43) | TNKSTSHRMETAP2CA1CA2 | |
| SCHEMBL13171003 | 0.80 | CA1 (0.51) | TNKSTSHRCA1CA2XDH | |
| SCHEMBL16945603 | 0.80 | CYP1A2 (0.40) | TNKSMAOBPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11296282-B2 | Organic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-04-05 | — | — | US | disclosed |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11296282-B2 | Organic compound and organic electroluminescence device using the same | SLCO4C1, EML4, SLCO2A1 | TNKS 4797/4885TSHR 4244/4885METAP2 1453/4885 |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, EML4, SLCO2A1 | TNKS 4797/4885TSHR 4244/4885METAP2 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.